Last reviewed · How we verify

Mepivacaine hydrochloride in combination with epinephrine

University of Nove de Julho · Phase 1 active Small molecule Quality 0/100

Mepivacaine hydrochloride in combination with epinephrine is a Small molecule drug developed by University of Nove de Julho. It is currently in Phase 1 development. Also known as: Local anesthetic.

At a glance

Generic nameMepivacaine hydrochloride in combination with epinephrine
Also known asLocal anesthetic
SponsorUniversity of Nove de Julho
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Mepivacaine hydrochloride in combination with epinephrine

What is Mepivacaine hydrochloride in combination with epinephrine?

Mepivacaine hydrochloride in combination with epinephrine is a Small molecule drug developed by University of Nove de Julho.

Who makes Mepivacaine hydrochloride in combination with epinephrine?

Mepivacaine hydrochloride in combination with epinephrine is developed by University of Nove de Julho (see full University of Nove de Julho pipeline at /company/university-of-nove-de-julho).

Is Mepivacaine hydrochloride in combination with epinephrine also known as anything else?

Mepivacaine hydrochloride in combination with epinephrine is also known as Local anesthetic.

What development phase is Mepivacaine hydrochloride in combination with epinephrine in?

Mepivacaine hydrochloride in combination with epinephrine is in Phase 1.

Related